Pinnacle West Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$306K Buy
6,350
+175
+3% +$8.16K 0.21% 97
2025
Q4
$299K Buy
6,175
+425
+7% +$21.1K 0.19% 97
2025
Q3
$271K Buy
5,750
+775
+16% +$37.4K 0.18% 104
2025
Q2
$240K Buy
4,975
+75
+2% +$3.83K 0.17% 108
2025
Q1
$272K Buy
4,900
+300
+7% +$16.2K 0.2% 103
2024
Q4
$222K Buy
4,600
+500
+12% +$25.4K 0.16% 109
2024
Q3
$236K Buy
+4,100
New +$221K 0.17% 109

Other funds holding SNY

Pinnacle West Asset Management's SNY Position: Q1 2026 in Review

Pinnacle West Asset Management increased its Sanofi (SNY) stake by 2.8% in Q1 2026, buying an estimated $8.16K and bringing the position to 6,350 shares worth $306K. The position accounts for 0.21% of the portfolio, ranked #97.

Pinnacle West Asset Management first reported a position in SNY in Q3 2024 and has held it in 7 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Pinnacle West Asset Management held 6,350 shares of Sanofi worth $306K as of Q1 2026.
  • Pinnacle West Asset Management bought 175 Sanofi shares in Q1 2026, an estimated $8.16K.
  • Sanofi made up 0.21% of Pinnacle West Asset Management's portfolio in Q1 2026, its #97 holding.
  • Pinnacle West Asset Management first reported a position in Sanofi in Q3 2024 and has held it in 7 quarters since.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Pinnacle West Asset Management's 13F filing for Q1 2026, filed 15 May 2026.